September 12, 2024 11:59 am
General public being misled by Entod Pharmaceuticals, says Drug Controller General of India. Company to challenge order
October 06, 2024 6:46 pm
A few days after granting its approval, drugs regulator DGCI suspended the manufacturing and marketing licence for the PresVu eye drop, saying Entod Pharmaceuticals had made misleading claims. Here's what you should know.
July 04, 2024 11:54 am
Indians will be able to access injectables of this class of drugs for the first time
April 20, 2023 3:30 am
The PIL, alleged that adulterated and substandard drugs being sold and manufactured in India
November 24, 2021 10:52 am
The company completed large-scale enrolment of its phase-3 clinical trials by early February in in patients with chronic kidney disease, both on dialysis and not on dialysis.
August 27, 2021 7:17 am
The Drug Controller General of India recently approved phase 2/3 study protocols of HGCO19, developed by Gennova Biopharmaceuticals Limited, a subsidiary of Pune-based Emcure Pharmaceuticals Limited.
May 17, 2019 1:51 am
According to a notification issued on Thursday by the CDSCO, the practice of changing the key therapeutic ingredients in a drug formulation without changing the brand name “is not only misleading but may also result in undesirable pharmacological effects as the consumer would take the formulation assuming that it has the earlier composition.”
June 19, 2018 2:17 am
This mechanism will be implemented across India on a trial basis to spot out counterfeit drugs.
June 21, 2017 12:05 am
Move to replace gelatin-based capsules with those made from plant products is not guided by medical reasons.
March 04, 2014 1:56 am
Drug controller post vacant since 2006, 11 drug inspector posts have become vacant in last three years




